Biotechnology Editas Medicine Announces Positive Safety and Efficacy Data from the First Two Patients Treated in the RUBY Trial of EDIT-301 for the Treatment of Severe Sickle Cell Disease December 6, 2022
Biotechnology Ascendis Pharma to Initiate TransCon(TM) PTH U.S. Expanded Access Program for Adult Patients with Hypoparathyroidism December 5, 2022
Biotechnology Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Clinical Utility and Benefit of clonoSEQ® MRD Testing in Blood Cancer Patients at 2022 ASH Annual Meeting December 5, 2022
Biotechnology Denali Therapeutics Announces DNL343 Interim Phase 1b Data in ALS and Entry into the HEALEY ALS Platform Trial December 5, 2022
Biotechnology BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS December 5, 2022
Biotechnology Moore Kuehn, PLLC Encourages Investors of Allogene Therapeutics, Inc. to Contact Law Firm December 4, 2022
Biotechnology Ultragenyx (RARE) Down 0.9% Since Last Earnings Report: Can It Rebound? December 2, 2022
Search
Biotechnology
